Edition: United States  
One News Page
“Probably the fastest-access news portal in the world”
> >

Zuckerberg Family Fund to Invest $3 Billion in Research Technology

Duration: 03:07s - Published: < > Embed
News video: Zuckerberg Family Fund to Invest $3 Billion in Research TechnologyMark ZuckerbergMark Zuckerberg
The Chan Zuckerberg Initiative, a philanthropic organization founded by Facebook CEO Mark Zuckerberg and his wife, Dr. Priscilla Chan, will invest $3 billion in disease research technology. Their initial investment will be $600 million to create a lab of engineers and scientists. WSJ's Lee Hawkins explains. Copyright 2016, Dow Jones & Company, Inc.


0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Mark Zuckerberg, Priscilla Chan to give UCSF $3 billion over 10 years

Facebook co-founder and CEO Mark Zuckerberg and wife Priscilla Chan, M.D., are pledging $3 billion to...
bizjournals - Business

Mark Zuckerberg's new $3 billion goal: Curing all disease

SAN FRANCISCO — Mark Zuckerberg and wife Priscilla Chan have set a new ambitious goal: curing...
Mashable - Internet

Zuckerberg, Chan to spend $3 billion on curing disease

Facebook founder Mark Zuckerberg and his wife, Dr. Priscilla Chan, on Wednesday announced a $3...
SFGate - Business

Mark Zuckerberg is about to spend $3 billion on trying to cure all diseases

Mark Zuckerberg is about to spend $3 billion on trying to cure all diseasesAs part of the work of the Chan Zuckerberg Initiative set up by himself and wife Priscilla last year,...
Digital Trends - Technology


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2016 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+